Andecaliximab is a recombinant IgG4 monoclonal antibody targeting matrix metalloproteinase 9 (MMP9). Andecaliximab showed antifibrotic effects in a mouse model of idiopathic pulmonary fibrosis. Andecaliximab can be used to study gastric adenocarcinoma an
CAS Number:
[1518996-49-0]
Target:
Virus Protease|||MMP
* VAT and and shipping costs not included. Errors and price changes excepted